The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Clinical trial NCT06377852 · RECRUITING

Trial details

NCT number: NCT06377852
Sponsor: American Society of Clinical Oncology
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2024-10-29
Primary completion: 2028-08-31
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.